ArticleARYA atherosclerosis2016

The outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: A longitudinal study in an Iranian population.

Morteza Abdar et al.PubMed ↗Full text ↗

No numbers read from the abstract.